Agilent Technologies (NYSE:A) Issues Q3 2025 Earnings Guidance

Agilent Technologies (NYSE:A - Get Free Report) updated its third quarter 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.350-1.370 for the period. The company issued revenue guidance of $1.6 billion-$1.7 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Trading Down 0.9%

Shares of NYSE A traded down $1.00 during trading on Monday, reaching $110.92. The company had a trading volume of 1,756,960 shares, compared to its average volume of 1,928,814. The stock has a market cap of $31.62 billion, a P/E ratio of 27.39, a PEG ratio of 3.40 and a beta of 1.23. The company's fifty day moving average price is $108.44 and its 200-day moving average price is $126.39. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. Agilent Technologies has a 12 month low of $96.43 and a 12 month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.26 by $0.05. The business had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The firm's revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.22 earnings per share. As a group, research analysts expect that Agilent Technologies will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.89%. The ex-dividend date of this dividend is Tuesday, July 1st. Agilent Technologies's dividend payout ratio (DPR) is presently 24.44%.

Analyst Upgrades and Downgrades

A number of analysts have commented on A shares. Barclays cut their price target on shares of Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. TD Cowen increased their price target on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a report on Thursday. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. Jefferies Financial Group dropped their target price on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Finally, JPMorgan Chase & Co. decreased their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research note on Thursday. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $140.15.

Insider Activity at Agilent Technologies

In related news, VP Rodney Gonsalves sold 1,908 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. This represents a 8.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares of the company's stock, valued at $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in A. Geneos Wealth Management Inc. grew its position in Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock worth $70,000 after purchasing an additional 212 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock valued at $602,000 after acquiring an additional 769 shares in the last quarter. Acadian Asset Management LLC increased its position in shares of Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock valued at $625,000 after acquiring an additional 758 shares during the last quarter. Finally, Brighton Jones LLC increased its position in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after acquiring an additional 270 shares during the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.